Historic 6th Annual Pharmaceutical Leadership Summit & Pharmaleaders Awards 2013 focused to give Aam Admi of India affordable medicines & Quality healthcare to rural india at Pharmaleaders 2013 Meet

Historic 6th Annual Pharmaceutical Leadership Summit & Pharmaleaders Awards 2013 focused to give Aam Admi of India affordable medicines & Quality healthcare to rural india at Pharmaleaders 2013 Meet

30DEC

ImageImageImageImageImageImageImageImageImageImageImageImageImageImageImage

Mayank Gandhi of Aam Admi Party & Satya Brahma of Pharmaleaders gave away prestigious honors & coveted awards to the shining stars of the Indian Pharmaceutical & Medical Professionals.

 

30th December 2013, Monday, Mumbai, Maharashtra, India: in a sequel to the sixty days of the voting by the Indian masses to select the best of the best in the final five nominees in various important categories & individual nonvoting categories, Pharmaleaders ( www.pharmaleaders.tv ) felicitated top performers in the healthcare industry & medical professionals in Mumbai on Friday,27th December 2013 at the historic 6th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2013 ( www.pharmaleaders2013.com ) at the hand of Mayank Gandhi, Member, National Executive of the Aam Admi Party. Organised by Pharmaleaders, Asia’s leading healthcare media in healthcare communications & a division of Network 7 Media Group, The platform witnessed more than 300 professionals of the healthcare industry.

Satya Brahma, Chairman & Editor-In-Chief of Pharmaleaders in the opening address lambasted the union government for the faulty healthcare reforms & policy paralysis. In a scathing attack to the UPA regime, NPPA, Health Ministry, Ministry of Chemicals & Fertilizers, Satya highlighted the series of issues neglected by the authorities & blamed the central government for not listening to the long-standing demands of the sensitive healthcare industry in DPCO logjam, FDI in Pharmaceuticals & the widening gap of the government & the vast majority of Indian masses who are deprived of the basic healthcare needs. The highlight of the seminar was the panel discussion on “Ethics in Medical Profession” where country’s top doctors & industry debated on the decline of ethics in medical profession & reached at the consensus that the industry & doctors must work closely to build a strong models to promote the dignity of the profession.

Addressing the industry leaders & leading faces of the medical profession, Mayank Gandhi, Chief Guest of the evening urged the industry to provide affordable medicines to the Aam Admis & criticized the government of not bringing industry friendly reforms. Mayank stressed the need of a clean politics & higher ethical standards of the rulers & launched a series of attack to the policy makers who underestimated the power of the Aam Admis. The arrogance of the legislators & Parliamentarians will no longer be tolerated as india is now prepared to give a befitting reply to the rulers if legislators failed to the demands of the masses.

The Evening Award ceremony was marked by the entry of the volunteers of the Aam Admi Party at the historic summit. Anjali Damania, Maharashtra State Convenor of the Aam Admi Party joined with Mayank Gandhi & Satya Brahma in the inaugural lamp lighting ceremony followed by the National Anthem in the packed house where the who’s & Who’s of the Indian healthcare industry were present. The Chief guest of the Pharmaleaders awards evening Mayank Gandhi accompanied by the Editor-In-Chief of the Pharmaleaders Satya Brahma conferred the prestigious & coveted titles to the leading faces of the Indian healthcare industry. The winners at the 6th Annual Pharmaceutical Leadership Summit & Awards are as following.

Voting Nomination Category Winners:

Rising Company of the year 2013

1.Galpha Laboratories Ltd.

Emerging Business Leader of the Year 2013

2.Dr Rajeev Modi

MD, Cadila Pharmaceuticals Ltd

3.Emerging Business Woman of The Year 2013

Ms. Nidhi Saxena

Founder & CEO, Karmic Lifesciences

4.Dynamic Entrepreneur of the Year 2013

Mr. Prakash Guha

MD, Zuventus Healthcare Ltd

5.India’s Most Respected Company by Medical Practitioners 2013

Zuventus Healthcare Ltd

6.India’s Best Managed Healthcare Chain 2013

Global Hospitals Group

7.Multinational Company of the year 2013

Abbott India Ltd

8.India’s Most Admired Company in Healthcare IT Solutions 2013

Infinite Computer Solutions (India) Ltd.

9.India’s Most Respected Cosmetic Dermatologist 2013

Dr.Chytra. V. Anand,

Founder, CEO & Chief Cosmetic Dermatologist, KOSMORDEMA

10.India’s Most Admired Company in CRAMS Market 2013

Akums Drugs & Pharmaceuticals Ltd

11.Emerging Company of the Year 2013

Menarini India Private Limited

12.Women Entrepreneur of the Year 2013

Dr. Nilyini G, Founder CEO, Blu Skin Cosmetology

13.CEO  of the year 2013

Mr. Rehan A. Khan

Managing Director, Abbott India

14.India’s Most Admired Company in Corporate Governance 2013

Aurobindo Pharma Ltd

15.Brand of The Year 2013

DOLO

16.Rising Brand of The Year 2013

Newbona (Akumentis Healthcare Ltd)

17.India’s Most Admired Pharma Company 2013

Alkem Laboratories Ltd.

18.India’s Fastest Growing Pharma Company 2013

Menarini India Private Limited

19.India’s Most Respected Healthcare Group To Work For 2013

Emcure Pharmaceuticals Ltd

20.India’s Fastest Growing Company in Contract Manufacturing 2013

Akums Drugs & Pharmaceuticals Ltd       

Non-Voting Category Winners :

 Image

ImageImageImageImageImageImageImageImageImageImageImageImage

ImageImageImageImageImageImageImageImageImageImageImageImage

ImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImage

ImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImage

ImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImage

ImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImage

Advertisements

Pharma Companies & Doctors need to widen the gap of meaningful dialogue in scientific & medical communications. Ethics in Medical Profession is key to sustainable growth & innovation – Satya Brahma

Pharma Companies & Doctors need to widen the gap of meaningful dialogue in scientific & medical communications. Ethics in Medical Profession is key to sustainable growth & innovation – Satya Brahma

Image 

Pharmaleaders 2013 annual & historic platform 6th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2013 organized by Network 7 Media Group’s Pharmaleaders, Asia’s most analytical healthcare media will raise the issue of greater interaction, meaningful interaction & dialogue between the Indian Medical Practitioners & the drug makers in the branded formulation market said Satya Brahma in an interview to IANS. Of late we have seen the widening gap of interaction in the form of updating clinical & medical communications to the Doctors by the Pharma Companies leading to the erosion of values in medical profession. Traditionally the standard practice of detailing to the doctors has been to update the doctors by the pharma companies through communication materials such as visual ads, product informations, new & research product launches. Doctors look at Medical Representatives as the tool to update their knowledge in latest breakthrough in medical research & look at the Pharma Companies as the reliable partner of their medical practice who reach out to them to get an endorsement of the product baskets.

FDI Policy, Clinical Trial Approvals, Compulsive licensing & the slowdown in the number of new product launches, regulatory challenges, the hostile economic environment in India, Drug Prices Control Order (DPCO) 2013 of lowering the prices of 348 essential drugs are some of the biggest challenges & worries for the leading Indian pharma companies seem to indicate that the lack of interest in staying in business leading to the wider  concentration on reaching out to the doctors.

“There is widespread report of an unholy nexus between the doctors & the pharma companies in cementing commercial deals are distressing & is increasing rapidly in india despite MCI guidelines. Give & Take seem to be the order of the day resulting in the erosion of ethics in medical profession. It is widely believed that pharma companies & doctors are engaged in dubious commercial transactions as pharma companies feel that doctors have multiple options available to endorse the products in regular product basket unless the pharma company has something new to offer which compel the doctors to prescribe. This is the focal point at the Summit as we attempt to bring face to face with the drug companies & doctors in the single platform said” Satya Brahma

Pharmaleaders believe that though the entire scenario is not the same as doctors & pharma companies know that it is only the research driven products & efficacy in drugs are key but the large portion of the market need to increase the interaction on strong medical values & ethics in profession. Entering in its 6th Year, the much anticipated & awaited prestigious title is attempting to revisit the current state of medical profession  & the pressure of building brands & most importantly, maintaining the sustainable growth record in an era where Government’s policy making machine making a difficult task to the thinking process & the strategies to retain market dominance. As Pharmaleaders march ahead to host the event, both domestic & international markets have been witnessing a change of approach. Indian pharmaceutical industry is globally ranked fourth in terms of volume, constituting 8% of total world’s production. Its value is estimated at $17 billion. India is now among the top five pharmaceutical emerging markets globally. The industry is expected to touch US$ 35.9 billion by 2016.

Pharmaleaders has padded some of the biggest names in the pharmaceutical & medical profession to debate on the wide ranging issues under the theme Incredible Pharmaleaders, Billion Dreams – Pushing India’s Growth on 27th December in Mumbai in india. Amongst the leaders who will address are Mr. Kewal Kanda,Promoter Director,Salus Lifecare Pvt Ltd on Decoding the success mantra of Indian Pharma Industry in an era of Govt regulations, Dr Mukesh Batra, Founder Chairman, Dr Batra’s Positive Health Clinic, on Challenges of Globalizing Homeopathic Medicines : A Dr Batra’s Case Study, Mr.Mahesh Zagade, Commissioner FDA, Maharashtra, Government of Maharashtra on Regulatory Challenges of Indian Plants. FDA Initiative to curb counterfeit drugs, Dr Shasank. R. Joshi ,Consulting Endocrinologist & Diabetologist on The Evolving Profile of the Indian Medical Practitioners : Doctors Expectations from the Pharmaceutical Companies – Beyond Gifts & Vacation Sponsorships, Mr. Deepak Naik,Managing Director, Health ‘N’ U Therapeutics Pvt. Ltd on Has the Pharmaceutical Companies failed to impress the doctors on medical education by adopting unethical means?, Dr.GSK Velu, Founder Chairman, Trivitron Group of Companies on Challenges & Oppourtunities of Indian Medical Device Industry, Dr Naresh Trehan, Cardiovascular and Cardiothoracic Surgeon & CMDS,Medanta on Making of India’s Leadership in Medical Innovation : The Real Time Experience, Dr. Shuba Dharmana, Cosmetic Dermatologist & Founder CEO, Le’jeune Medspa on The Changing Face of Indian Skincare Innovations, Prof. Dr. Nandkishore Shamrao Laud, Founder, Dr Laud Clinic on Cost effective Healthcare through citizens community participation.S. Krishnakumar of Future Steps will moderate the event. Dr. Kancherla Ravindranath, CMD, Global Hospitals Group, Dr. Kaushal Pandey, Cardiac Surgeon, Dr. Sudhir Vaishnav, Interventional Cardiologist, Dr Deepak K Jhumani, Consultant in Sexual Health and Counsellor, Dr. Harish S. Bhende Orthopaedic Surgeon, Dr. Chytra v Anand, Founder&CEO & Chief Cosmetic Dermatologist, KOSMODERMA, Dr.Deepak Chaturvedi, Physician Endocrinologist & Dialectologist, Dr. Rashmi Shetty, Non-Surgical Aesthetic Medicine Expert will join in to a high voltage panel discussion on Ethics in Medical Profession. More than 250 Industry Leaders, Healthcare Experts, Pharma Academia, policy makers will be attending this historic summit.

 6th Annual Pharmaceutical Leadership Summit 2013  will also felicitate the top doctors & pharma companies in 40 categories in a glittering award night. 

Pharma Companies & Doctors need to widen the gap of meaningful dialogue in scientific & medical communications. Ethics in Medical Profession is key to sustainable growth & innovation – Satya Brahma

Pharma Companies & Doctors need to widen the gap of meaningful dialogue in scientific & medical communications. Ethics in Medical Profession is key to sustainable growth & innovation – Satya Brahma

Image 

Pharmaleaders 2013 annual & historic platform 6th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2013 organized by Network 7 Media Group’s Pharmaleaders, Asia’s most analytical healthcare media will raise the issue of greater interaction, meaningful interaction & dialogue between the Indian Medical Practitioners & the drug makers in the branded formulation market said Satya Brahma in an interview to IANS. Of late we have seen the widening gap of interaction in the form of updating clinical & medical communications to the Doctors by the Pharma Companies leading to the erosion of values in medical profession. Traditionally the standard practice of detailing to the doctors has been to update the doctors by the pharma companies through communication materials such as visual ads, product informations, new & research product launches. Doctors look at Medical Representatives as the tool to update their knowledge in latest breakthrough in medical research & look at the Pharma Companies as the reliable partner of their medical practice who reach out to them to get an endorsement of the product baskets.

FDI Policy, Clinical Trial Approvals, Compulsive licensing & the slowdown in the number of new product launches, regulatory challenges, the hostile economic environment in India, Drug Prices Control Order (DPCO) 2013 of lowering the prices of 348 essential drugs are some of the biggest challenges & worries for the leading Indian pharma companies seem to indicate that the lack of interest in staying in business leading to the wider  concentration on reaching out to the doctors.

“There is widespread report of an unholy nexus between the doctors & the pharma companies in cementing commercial deals are distressing & is increasing rapidly in india despite MCI guidelines. Give & Take seem to be the order of the day resulting in the erosion of ethics in medical profession. It is widely believed that pharma companies & doctors are engaged in dubious commercial transactions as pharma companies feel that doctors have multiple options available to endorse the products in regular product basket unless the pharma company has something new to offer which compel the doctors to prescribe. This is the focal point at the Summit as we attempt to bring face to face with the drug companies & doctors in the single platform said” Satya Brahma

Pharmaleaders believe that though the entire scenario is not the same as doctors & pharma companies know that it is only the research driven products & efficacy in drugs are key but the large portion of the market need to increase the interaction on strong medical values & ethics in profession. Entering in its 6th Year, the much anticipated & awaited prestigious title is attempting to revisit the current state of medical profession  & the pressure of building brands & most importantly, maintaining the sustainable growth record in an era where Government’s policy making machine making a difficult task to the thinking process & the strategies to retain market dominance. As Pharmaleaders march ahead to host the event, both domestic & international markets have been witnessing a change of approach. Indian pharmaceutical industry is globally ranked fourth in terms of volume, constituting 8% of total world’s production. Its value is estimated at $17 billion. India is now among the top five pharmaceutical emerging markets globally. The industry is expected to touch US$ 35.9 billion by 2016.

Pharmaleaders has padded some of the biggest names in the pharmaceutical & medical profession to debate on the wide ranging issues under the theme Incredible Pharmaleaders, Billion Dreams – Pushing India’s Growth on 27th December in Mumbai in india. Amongst the leaders who will address are Mr. Kewal Kanda,Promoter Director,Salus Lifecare Pvt Ltd on Decoding the success mantra of Indian Pharma Industry in an era of Govt regulations, Dr Mukesh Batra, Founder Chairman, Dr Batra’s Positive Health Clinic, on Challenges of Globalizing Homeopathic Medicines : A Dr Batra’s Case Study, Mr.Mahesh Zagade, Commissioner FDA, Maharashtra, Government of Maharashtra on Regulatory Challenges of Indian Plants. FDA Initiative to curb counterfeit drugs, Dr Shasank. R. Joshi ,Consulting Endocrinologist & Diabetologist on The Evolving Profile of the Indian Medical Practitioners : Doctors Expectations from the Pharmaceutical Companies – Beyond Gifts & Vacation Sponsorships, Mr. Deepak Naik,Managing Director, Health ‘N’ U Therapeutics Pvt. Ltd on Has the Pharmaceutical Companies failed to impress the doctors on medical education by adopting unethical means?, Dr.GSK Velu, Founder Chairman, Trivitron Group of Companies on Challenges & Oppourtunities of Indian Medical Device Industry, Dr Naresh Trehan, Cardiovascular and Cardiothoracic Surgeon & CMDS,Medanta on Making of India’s Leadership in Medical Innovation : The Real Time Experience, Dr. Shuba Dharmana, Cosmetic Dermatologist & Founder CEO, Le’jeune Medspa on The Changing Face of Indian Skincare Innovations, Prof. Dr. Nandkishore Shamrao Laud, Founder, Dr Laud Clinic on Cost effective Healthcare through citizens community participation.S. Krishnakumar of Future Steps will moderate the event. Dr. Kancherla Ravindranath, CMD, Global Hospitals Group, Dr. Kaushal Pandey, Cardiac Surgeon, Dr. Sudhir Vaishnav, Interventional Cardiologist, Dr Deepak K Jhumani, Consultant in Sexual Health and Counsellor, Dr. Harish S. Bhende Orthopaedic Surgeon, Dr. Chytra v Anand, Founder&CEO & Chief Cosmetic Dermatologist, KOSMODERMA, Dr.Deepak Chaturvedi, Physician Endocrinologist & Dialectologist, Dr. Rashmi Shetty, Non-Surgical Aesthetic Medicine Expert will join in to a high voltage panel discussion on Ethics in Medical Profession. More than 250 Industry Leaders, Healthcare Experts, Pharma Academia, policy makers will be attending this historic summit.

 6th Annual Pharmaceutical Leadership Summit 2013  will also felicitate the top doctors & pharma companies in 40 categories in a glittering award night. 

India’s Top Doctors & Industry Stalwarts to debate at historic 6th Annual Pharmaceutical Leadership Summit & Leadership Awards 2013

 

India’s Top Doctors & Industry Stalwarts to debate at historic 6th Annual Pharmaceutical Leadership Summit & Leadership Awards 2013

Dr Naresh Trehan, Dr NS Laud, Dr Mukesh Batra,Dr Shasank Joshi, Dr. G.S.K. Velu,Dr Chytra Anand, Dr Kaushal Pandey, Dr Harish Bhende, Dr Sudhir Vaishnav, Dr Jythydev Kesavadav,Dr Shuba Dharmana,Kewal Handa, Deepak Naik,Dr Hasit Joshipura among others to review the pulse of india healthcare sector

Image

Wednesday,4th December 2013, Mumbai, Maharashtra, India : The state of the indian pharmaceutical & healthcare industry is definitely not in good shape as the nation has witnessed series of policy paralysis & the stand-off between the industry & the government. The latest blow to this is in in FDI in Pharma where the government has decided to continue with the existing policy on foreign direct investment in the pharmaceutical sector and not implement the revised policy proposed by the industry ministry. However, an additional condition has been imposed that in all cases of FDI in Brownfield pharma projects, there will be no non-compete clause in any of the inter se agreements. There is also a deep concern with regard to the image of the pharma industry in india due to the severe attack from the regulatory bodies such as US FDA. Pricing continues to be the challenging factor as majority of essential drugs are controlled by the pricing mechanism of the government. Healthcare insurance again is a concept in womb in india. The state of medical profession in india still needs to be improved given the huge requirements of doctors. It seems political priorities have overtaken Indian growth story.

Keeping in view the seriousness of the topic where the government has repeatedly failed to give a leadership direction & listen to the Indian drug makers coupled with the lack of a healthy dialogue between the doctors & the pharma companies, Pharmaleaders ( www.pharmaleaders.tv ), a division of Network 7 Media Group, is organizing its 6th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2013 ( www.pharmaleaders2013.com ) at hotel hilton mumbai international airport on Friday 27th December 2013 in india under the theme Incredible Pharmaleaders 2013, Billion Dreams – Pushing India’s Growth Agenda. Speaking to media on the Pharmaleaders 2013 annual meet, Satya Brahma, Chairman & Editor-In-Chief of Pharmaleaders said “ With the increasing pressure of the Indian pharmaceutical, Biotech Companies & Healthcare Firms to maintain the efficacy of the products & services in an era of price control, government regulation & international regulatory agencies to keep a alert on the companies to adhere to quality norms, the pharmaleaders forum attempt to bring a qualitative change in the minds of the pharmaleaders by bringing top leaders of the country in single plattform from the pharmaceutical, healthcare, biotechnology & medical profession to debate the significant issues grappling the country today. India’s branded formulation market has become fiercely competitive due to the pricing mechanism, regulatory challenges & FDI in Pharma sector” said  Satya Brahma.

Pharmaleaders has lined up top notch professionals to debate on wide array of subjects. Country’s top leaders in healthcare will debate to raise issues of far reaching consequences. Amongst the leaders who will address are Mr. Kewal Kanda,Promoter Director,Salus Lifecare Pvt Ltd on Decoding the success mantra of Indian Pharma Industry in an era of Govt regulations, Dr Mukesh Batra, Founder Chairman, Dr Batra’s Positive Health Clinic, on Challenges of Globalizing Homeopathic Medicines : A Dr Batra’s Case Study, Mr.Mahesh Zagade, Commissioner FDA, Maharashtra, Government of Maharashtra on Regulatory Challenges of Indian Plants. FDA Initiative to curb counterfeit drugs, Dr Shasank. R. Joshi ,Consulting Endocrinologist & Diabetologist on The Evolving Profile of the Indian Medical Practitioners : Doctors Expectations from the Pharmaceutical Companies – Beyond Gifts & Vacation Sponsorships, Mr. Deepak Naik,Managing Director, Health ‘N’ U Therapeutics Pvt. Ltd on Has the Pharmaceutical Companies failed to impress the doctors on medical education by adopting unethical means?, Dr.GSK Velu, Founder Chairman, Trivitron Group of Companies on Challenges & Oppourtunities of Indian Medical Device Industry, Dr Naresh Trehan, Cardiovascular and Cardiothoracic Surgeon & CMDS,Medanta on Making of India’s Leadership in Medical Innovation : The Real Time Experience, Dr. Shuba Dharmana,Cosmetic Dermatologist & Founder CEO, Le’jeune Medspa on The Changing Face of Indian Skincare Innovations, Prof. Dr. Nandkishore Shamrao Laud, Founder, Dr Laud Clinic on Cost effective Healthcare through citizens community participation.S. Krishnakumar of Future Steps will moderate the event.

Dr. Kaushal Pandey, Cardiac Surgeon, Dr. Sudhir Vaishnav, Interventional Cardiologist, Dr Deepak K Jhumani, Consultant in Sexual Health and Counsellor, Dr. Harish S. Bhende Orthopaedic Surgeon, Dr. Chytra v Anand, Founder&CEO & Chief Cosmetic Dermatologist, KOSMODERMA, Dr.Deepak Chaturvedi, Physician Endocrinologist & Dialectologist, Dr. Rashmi Shetty, Non-Surgical Aesthetic Medicine Expert will join in to a high voltage panel discussion on Ethics in Medical Profession. More than 250 Industry Leaders, Healthcare Experts, Pharma Academia, policy makers will be attending this historic summit.  

The healthcare sector in India will grow to $158.2 billion in 2017 from $78.6 billion in 2012, a report has said. “The healthcare sector is growing at a 15% CAGR and jumped from $45 billion in 2008 to $78.6 billion in 2012 and expected to touch $158.2 billion by 2017,The factors behind the growth is rising incomes, easier access to high-quality healthcare facilities and greater awareness of personal health and hygiene. The country’s healthcare system is developing rapidly and it continues to expand its coverage, services and spending in both the public as well as private sectors. The private sector has emerged as a vibrant force in India’s healthcare industry, lending it both national and international repute. Private sector’s share in healthcare delivery is expected to increase from 66% in 2005 to 81% by 2015. Private sector’s share in hospitals and hospital beds is estimated at 74% and 40%, respectively. There is substantial demand for high-quality and speciality healthcare services in tier-II and tier-III cities. To encourage the private sector to establish hospitals in these cities, government has relaxed the taxes on these hospitals for the first 5 years.Over the years, health insurance is gaining momentum in India; gross healthcare insurance premium is expanding at a CAGR of 39% over FY06-10. This trend is likely to continue, benefitting the country’s healthcare industry.Strong mobile technology infrastructure and launch of 4G is expected to drive mobile health initiatives in the country. Mobile health industry in India is expected to reach $0.6 billion by 2017.To standardize the quality of service delivery, control cost and enhance patient engagement, healthcare providers are focussing on the technological aspect of healthcare delivery.Digital health knowledge resources, electronic medical record, mobile healthcare, hospital information system are some of the technologies gaining acceptance in the sector. Going forward, the healthcare sector’s spending on IT products and services is expected to rise from $53 billion in 2012 to $57 billion in 2013.

 

The 6th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards will also felicitate top performers in 30 award categories besides individual recognition from the jury members to the ambassadors of Indian healthcare industry.